drugset / Trial / NCT00239408
Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).
RandomizedParallel-groupDouble-blindTreatment
Summary
Evaluate whether the effect of inhaled tiotropium bromide on the change in trough forced expiratory volume (FEV1), compared to placebo in patients with chronic obstructive pulmonary disease (COPD), is affected by smoking status.
Timeline
- Start
- 2002-12
- Primary completion
- 2004-04
- Completion
- 2004-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tiotropium | Other / unclassified | 18 ug | Inhaled |